Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.11 | 0.7 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |